Rogier Versteeg

Rogier Versteeg

UNVERIFIED PROFILE

Are you Rogier Versteeg?   Register this Author

Register author
Rogier Versteeg

Rogier Versteeg

Publications by authors named "Rogier Versteeg"

Are you Rogier Versteeg?   Register this Author

100Publications

4071Reads

18Profile Views

Recruitment of BRCA1 limits MYCN-driven accumulation of stalled RNA polymerase.

Nature 2019 03 20;567(7749):545-549. Epub 2019 Mar 20.

Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41586-019-1030-9DOI Listing
March 2019

Indian Hedgehog Suppresses a Stromal Cell-Driven Intestinal Immune Response.

Cell Mol Gastroenterol Hepatol 2018 5;5(1):67-82.e1. Epub 2017 Sep 5.

Tytgat Institute for Liver and Intestinal Research, Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcmgh.2017.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738458PMC
September 2017

Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity.

Eur J Cancer 2017 04 17;75:63-72. Epub 2017 Feb 17.

Department of Translational Medicine, Prinses Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.12.019DOI Listing
April 2017

DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells.

PLoS One 2015 30;10(12):e0145744. Epub 2015 Dec 30.

Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145744PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696738PMC
June 2016

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

Authors:
Dominik Sturm Brent A Orr Umut H Toprak Volker Hovestadt David T W Jones David Capper Martin Sill Ivo Buchhalter Paul A Northcott Irina Leis Marina Ryzhova Christian Koelsche Elke Pfaff Sariah J Allen Gnanaprakash Balasubramanian Barbara C Worst Kristian W Pajtler Sebastian Brabetz Pascal D Johann Felix Sahm Jüri Reimand Alan Mackay Diana M Carvalho Marc Remke Joanna J Phillips Arie Perry Cynthia Cowdrey Rachid Drissi Maryam Fouladi Felice Giangaspero Maria Łastowska Wiesława Grajkowska Wolfram Scheurlen Torsten Pietsch Christian Hagel Johannes Gojo Daniela Lötsch Walter Berger Irene Slavc Christine Haberler Anne Jouvet Stefan Holm Silvia Hofer Marco Prinz Catherine Keohane Iris Fried Christian Mawrin David Scheie Bret C Mobley Matthew J Schniederjan Mariarita Santi Anna M Buccoliero Sonika Dahiya Christof M Kramm André O von Bueren Katja von Hoff Stefan Rutkowski Christel Herold-Mende Michael C Frühwald Till Milde Martin Hasselblatt Pieter Wesseling Jochen Rößler Ulrich Schüller Martin Ebinger Jens Schittenhelm Stephan Frank Rainer Grobholz Istvan Vajtai Volkmar Hans Reinhard Schneppenheim Karel Zitterbart V Peter Collins Eleonora Aronica Pascale Varlet Stephanie Puget Christelle Dufour Jacques Grill Dominique Figarella-Branger Marietta Wolter Martin U Schuhmann Tarek Shalaby Michael Grotzer Timothy van Meter Camelia-Maria Monoranu Jörg Felsberg Guido Reifenberger Matija Snuderl Lynn Ann Forrester Jan Koster Rogier Versteeg Richard Volckmann Peter van Sluis Stephan Wolf Tom Mikkelsen Amar Gajjar Kenneth Aldape Andrew S Moore Michael D Taylor Chris Jones Nada Jabado Matthias A Karajannis Roland Eils Matthias Schlesner Peter Lichter Andreas von Deimling Stefan M Pfister David W Ellison Andrey Korshunov Marcel Kool

Cell 2016 Feb;164(5):1060-1072

Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://www.cell.com/cell/pdf/S0092-8674(16)00055-6.pdf
Web Search
http://www.cell.com/cms/attachment/2048488015/2058390163/mmc
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S009286741600055
Publisher Site
http://dx.doi.org/10.1016/j.cell.2016.01.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139621PMC
February 2016

Targeting ALK: The Ten Lives of a Tumor.

Cancer Discov 2016 Jan;6(1):20-1

Department of Pediatric Hematology and Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-1411DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709027PMC
January 2016

TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.

Nat Genet 2015 Dec 2;47(12):1411-4. Epub 2015 Nov 2.

Department of Oncogenomics, Academic Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3438DOI Listing
December 2015

Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use.

Int J Cancer 2015 Aug 20;137(4):868-77. Epub 2015 Feb 20.

Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29461DOI Listing
August 2015

The role of histone demethylase KDM4B in Myc signaling in neuroblastoma.

J Natl Cancer Inst 2015 Jun 29;107(6):djv080. Epub 2015 Apr 29.

Department of Surgery (JY, AMA, DH, PHC, CLM, AMD) and Department of Bioinformatics (CQ), St. Jude Children's Research Hospital, Memphis, TN; Yale Cardiovascular Research Center, Yale School of Medicine, New Haven, CT (YW); Department of Oncology, University College London Cancer Institute, London, UK (ACN); Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX (JMS); Division of Biomedical Research, Foundation of Research and Technology-Hellas, Institute of Molecular Biology and Biotechnology, Ioannina, Greece (TF); Laboratory of Biological Chemistry, Medical School, University of Ioannina, Ioannina, Greece (TF); Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands (JK, RV); Kinki University Faculty of Medicine, Osaka-Sayama, Osaka, Japan (HO); Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK (ALH).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555638PMC
June 2015

Whole-genome sequencing identifies patient-specific DNA minimal residual disease markers in neuroblastoma.

J Mol Diagn 2015 Jan 24;17(1):43-52. Epub 2014 Oct 24.

Landsteiner Laboratory, Department of Pediatric Oncology, Emma Children's Hospital, Academical Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2014.09.005DOI Listing
January 2015

Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance.

Invest New Drugs 2014 Dec 7;32(6):1167-80. Epub 2014 Sep 7.

Laboratory of Experimental Oncology, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, 40136, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0158-6DOI Listing
December 2014

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.

Nature 2014 Jul 22;511(7510):428-34. Epub 2014 Jun 22.

1] Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg 69120, Germany [2] Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Im Neuenheimer Feld 430, Heidelberg 69120, Germany.

View Article

Download full-text PDF

Source
http://www.abta.org/resources/enhancers-hijacking-activates.
Web Search
http://www.nature.com/doifinder/10.1038/nature13379
Publisher Site
http://dx.doi.org/10.1038/nature13379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201514PMC
July 2014

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.

Cancer Cell 2014 Mar;25(3):393-405

Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69121 Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2014.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493053PMC
March 2014

Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours.

Eur J Cancer 2014 Feb 6;50(3):628-37. Epub 2013 Dec 6.

Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.11.015DOI Listing
February 2014

Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma.

Cancer Res 2014 Feb 12;74(3):765-74. Epub 2013 Dec 12.

Authors' Affiliations: Texas Children's Cancer Center and Center for Cell and Gene Therapy; Department of Surgery, Baylor College of Medicine, Houston, Texas; Center for Medical Genetics, Ghent University, Ghent, Belgium; CEINGE Biotecnologie Avanzate, Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Naples; Pediatric Research Institute, University of Padua, Padua; Paediatric Oncology and Haematology Unit "Lalla Seràgnoli," Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy; and Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/74/3/765.full.pdf
Web Search
http://cancerres.aacrjournals.org/content/early/2013/12/12/0
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-1315DOI Listing
February 2014

Discovery and visualization of miRNA-mRNA functional modules within integrated data using bicluster analysis.

Nucleic Acids Res 2014 Feb 18;42(3):e17. Epub 2013 Dec 18.

Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, York House, York Street, Dublin 2, Ireland, National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin 12, Ireland and Department of Oncogenomics, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkt1318DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919560PMC
February 2014

Cancer: Tumours outside the mutation box.

Authors:
Rogier Versteeg

Nature 2014 Feb 19;506(7489):438-9. Epub 2014 Feb 19.

Department of Oncogenomics, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature13061DOI Listing
February 2014

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.

Nat Genet 2013 Aug 30;45(8):927-32. Epub 2013 Jun 30.

Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://pubman.mpdl.mpg.de/pubman/item/escidoc:1982973/compon
Web Search
http://www.nature.com/doifinder/10.1038/ng.2682
Publisher Site
http://dx.doi.org/10.1038/ng.2682DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951336PMC
August 2013

snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.

Transl Oncol 2013 Aug 1;6(4):447-57. Epub 2013 Aug 1.

Center for Molecular Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730020PMC
http://dx.doi.org/10.1593/tlo.13112DOI Listing
August 2013

A NOTCH3 transcriptional module induces cell motility in neuroblastoma.

Clin Cancer Res 2013 Jul 6;19(13):3485-94. Epub 2013 May 6.

Department of Oncogenomics, Academic Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3021DOI Listing
July 2013

FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastoma.

Cancer Res 2013 Apr 1;73(7):2189-98. Epub 2013 Feb 1.

Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-3767DOI Listing
April 2013

OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.

Acta Neuropathol 2013 Mar 18;125(3):385-94. Epub 2012 Nov 18.

Department of Oncogenomics, Academic Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00401-012-1069-2DOI Listing
March 2013

Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth.

Eur J Cancer 2012 Nov 25;48(16):3093-103. Epub 2012 Feb 25.

Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.01.037DOI Listing
November 2012

Arrangement of nuclear structures is not transmitted through mitosis but is identical in sister cells.

J Cell Biochem 2012 Nov;113(11):3313-29

Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Královopolská 135, CZ-612 65 Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.24208DOI Listing
November 2012

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification.

Proc Natl Acad Sci U S A 2012 Nov 22;109(47):19190-5. Epub 2012 Oct 22.

Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1208215109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511149PMC
November 2012

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Cancer Cell 2012 Oct;22(4):425-37

Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) Heidelberg, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2012.08.024DOI Listing
October 2012

OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells.

Int J Cancer 2012 Jul 8;131(2):E21-32. Epub 2011 Nov 8.

Department of Oncogenomics, Academic Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.26474DOI Listing
July 2012

Identification of BIRC6 as a novel intervention target for neuroblastoma therapy.

BMC Cancer 2012 Jul 12;12:285. Epub 2012 Jul 12.

Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO box 22700, Amsterdam, AZ 1105, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495678PMC
July 2012

Stability of PCR targets for monitoring minimal residual disease in neuroblastoma.

J Mol Diagn 2012 Mar-Apr;14(2):168-75. Epub 2012 Jan 16.

Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2011.12.002DOI Listing
June 2012

Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer.

Clin Cancer Res 2012 Jun 10;18(11):3132-41. Epub 2012 Apr 10.

Laboratory for Experimental Oncology and Radiobiology, Center for Experimental Molecular Medicine, Academic Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-3066DOI Listing
June 2012

A top-down analysis of Xa- and Xi-territories reveals differences of higher order structure at ≥ 20 Mb genomic length scales.

Nucleus 2011 Sep-Oct;2(5):465-77. Epub 2011 Sep 1.

Biocenter, Department Biology II, Ludwig Maximilians University (LMU), Martinsried, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/nucl.2.5.17862DOI Listing
March 2012

Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression.

Eur J Cancer 2012 Mar 14;48(5):763-71. Epub 2011 Nov 14.

Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980491100799
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2011.10.012DOI Listing
March 2012

Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma.

Clin Cancer Res 2012 Feb 5;18(3):808-14. Epub 2011 Dec 5.

Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-0849DOI Listing
February 2012

Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe.

Endocr Relat Cancer 2011 Oct 27;18(6):657-68. Epub 2011 Oct 27.

Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22700, 1105 AZ Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-11-0207DOI Listing
October 2011

Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis.

Mol Carcinog 2011 Jun 28;50(6):403-11. Epub 2010 Dec 28.

Departments of Cancer Genetics, Royal College of Surgeons in Ireland, York House, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.20722DOI Listing
June 2011

Efficient double fragmentation ChIP-seq provides nucleotide resolution protein-DNA binding profiles.

PLoS One 2010 Nov 30;5(11):e15092. Epub 2010 Nov 30.

Cancer Genomics Center, Department of Medical Genetics, Hubrecht Institute and University Medical Center Utrecht, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0015092PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994895PMC
November 2010

Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.

Mol Cancer Res 2010 Oct 13;8(10):1344-57. Epub 2010 Sep 13.

Department of Human Genetics, Academic Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-09-0546DOI Listing
October 2010

NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.

Cell 2010 Jul;142(2):218-29

Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics and Cancer Genomics Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2010.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913027PMC
July 2010

MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3.

Cancer Lett 2010 Mar 7;289(2):195-207. Epub 2009 Oct 7.

Department of Human Genetics, Academic Medical Center, University of Amsterdam, AZ Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2009.08.019DOI Listing
March 2010

Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.

Cancer Res 2010 Jan 12;70(2):762-71. Epub 2010 Jan 12.

Department of Human Genetics, Academic Medical Centre, University of Amsterdam, Amsterdam 1105 AZ, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-2532DOI Listing
January 2010

Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells.

Proc Natl Acad Sci U S A 2009 Aug 12;106(31):12968-73. Epub 2009 Jun 12.

Department of Human Genetics, Academic Medical Center, Department of Pediatric Oncology, Emma Kinderziekenhuis, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO box 22700, 1105 AZ Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0901418106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695754PMC
August 2009

Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers.

Clin Chem 2009 Jul 21;55(7):1316-26. Epub 2009 May 21.

Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2008.117945DOI Listing
July 2009

The construction of genome-based transcriptional units.

OMICS 2009 Apr;13(2):105-14

Bioinformatics Laboratory, Academic Medical Center, Meibergdreef 9, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/omi.2008.0036DOI Listing
April 2009

ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.

Cancer Cell 2009 Apr;15(4):328-40

Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Center, The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2009.02.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693316PMC
April 2009

Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma.

Cancer Res 2008 Apr;68(8):2599-609

Department of Human Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-5032DOI Listing
April 2008